On the other side, biological behavior plays the decisive role in prognosis of advanced-stage HCC, HCC patients with thrombocytopenia which reflected less thrombopoietin and IL-6 induced by less malignant tumor would have a better prognosis. This evidence concerns the gene IL6 and Thrombocytopenia.